The Company and Description of Business (Details) - 1 months ended May. 31, 2015	Doses Infant Site
29 to 34 weeks gestational age [Member]
Description of Business [Line Items]
Number of dose groups enrolled for clinical trials | Doses	2
Number of premature infants undergoing surfactant doses	48
Number of additional infants undergoing surfactant doses	32
26 to 28 weeks gestational age [Member]
Description of Business [Line Items]
Number of premature infants undergoing surfactant doses	32
26 to 32 weeks gestational age [Member]
Description of Business [Line Items]
Number of escalating doses | Doses	2
Number of clinical sites | Site	50
Minimum [Member] | 29 to 34 weeks gestational age [Member]
Description of Business [Line Items]
Gestational age tolerability limit	1 hour
Minimum [Member] | 26 to 28 weeks gestational age [Member]
Description of Business [Line Items]
Gestational age tolerability limit	30 minutes
Minimum [Member] | 26 to 32 weeks gestational age [Member]
Description of Business [Line Items]
Number of premature infants undergoing surfactant doses	200
Maximum [Member] | 29 to 34 weeks gestational age [Member]
Description of Business [Line Items]
Gestational age tolerability limit	1 hour 30 minutes
Maximum [Member] | 26 to 28 weeks gestational age [Member]
Description of Business [Line Items]
Gestational age tolerability limit	45 minutes
Maximum [Member] | 26 to 32 weeks gestational age [Member]
Description of Business [Line Items]
Number of premature infants undergoing surfactant doses	250